Hepion Pharmaceuticals, Inc. announced Daren Ure, PhD; Daniel Trepanier, PhD; and Patrick Mayo, PhD have accepted the new roles of Hepion Pharmaceutical's Chief Scientific Officer; Senior Vice President of Drug Development; and Senior Vice President of Clinical Pharmacology; respectively. Dr. Ure has been working on cyclosporins and cyclophilins since 2003. Dr. Ure was a Research Scientist at Isotechnika Pharmaceuticals (now Aurinia Pharmaceuticals) and then the Director of Research and Development at Ciclofilin Pharmaceuticals. Dr. Trepanier has more than 22 years of experience in the pharmaceutical industry, all of which relates to cyclophilins. Dr. Mayo has 20 years of experience in the pharmaceutical industry. He has been working on cyclophilins since 1983, focusing on cyclosporine, tacrolimus and voclosporin.